# Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

> **NCT03190694** · PHASE2 · COMPLETED · sponsor: **Hiddo Lambers Heerspink** · enrollment: 53 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Proteinuria

## Interventions

- **DRUG:** Dapagliflozin 10mg

## Key facts

- **NCT ID:** NCT03190694
- **Lead sponsor:** Hiddo Lambers Heerspink
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-12
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2024-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03190694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03190694, "Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03190694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*